Response to erythropoietin and moxifloxacin in a patient with myelodysplastic syndrome non-respondent to erythropoietin alone.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12446199.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a low-risk myelodysplastic syndrome patient who did not respond to erythropoietin alone, but who did show a major erythroid response to combination therapy consisting of erythropoietin and moxifloxacin. This observation was exclusively empirical. The immunomodulatory effects of moxifloxacin may explain the synergy with erythropoietin.